- Research

Germans Trias surgeons devise Rutilight® to improve illumination during operations.

The spin-off company Swan Medical SL, of which the IGTP is a shareholder, is responsible for production and distribution of the product, baptised Rutilight®, that can be adapted to all current surgical instruments to provide a spotlight on the operating area. The new device eliminates shadows in the operating area and illuminates places that are difficult to access. The tool has been invented by surgeons for surgeons

- Campus Can Ruti

A trial in advanced colorectal cancer opens the door to a future blood test to predict the most efficient treatment for reducing metastasis

The study, published in 'Annals of Oncology' aimed to demonstrate that choosing the treatment regime based on genetic variants could improve the prognosis of patients with advanced colorectal cancer. Although this primary objective was not achieved, the trial did show that a blood test can be used to predict the most efficient treatment to reduce metastasis.

- Institutional

La 6a edició del programa Talents lliura les beques d’enguany i estrena ajuts per a la intensificació de recerca

Aquest dimecres dia 29 s'han lliurat els ajuts del Programa Talents de la Fundació Catalunya-La Pedrera i l'Hospital Germans Trias i Pujol. La 6a edició del programa premia 9 professionals de l'hospital Germans Trias i 4 d'Atenció Primària per fer recerca a l'IGTP i, a més, s'amplia amb les beques Germans Trias Sapiens, per a la intensificació de recerca a professionals de l'Hospital.